Duloxetine Capsule, Delayed Release
Product Images NDC 68788-7672

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 68788-7672). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Duloxetine Delayed Release Cap Usp 60mg

Duloxetine Delayed Release Cap Usp 60mg
This is a medication called Duloxetine, in the form of delayed-release capsules. Each capsule contains 60mg of the active ingredient, duloxetine hydrochloride. It is a generic version of the brand name drug Cymbalta. The medication is manufactured by Ajanta Pharma USA Inc. The label contains information such as lot number, batch number, and expiration date. The instructions caution against giving the medication to anyone other than the intended patient. There are also dosage instructions in English and Spanish. The text appears to be a product label or package insert for this medication.*
FDA Label Image

Duloxetine Fig1

FDA Label Image

Duloxetine Fig10

Duloxetine Fig10
This appears to be a medication regimen, involving a placebo and duloxetine at either 60mg or 120mg once daily for pain relief. There is also a graph showing a percent improvement in pain from a baseline measurement.*
FDA Label Image

Duloxetine Fig2

Duloxetine Fig2
This looks like a graph showing the proportion of patients with relapse over time, with treatment options of placebo and Duloxetine. The X-axis measures the time from randomization to relapse in days, while the Y-axis measures the percentage of patients. It seems that Duloxetine may have a lower proportion of patients with a relapse compared to the placebo.*
FDA Label Image

Duloxetine Fig3

FDA Label Image

Duloxetine Fig4

FDA Label Image

Duloxetine Fig5

Duloxetine Fig5
The text describes a chart showing the percentage of patients who improved with different treatments for pain. The treatments listed are Duloxetine 60mg twice daily, Duloxetine 60mg once daily, and placebo. The chart also displays the percentage improvement in pain from the baseline for each treatment.*
FDA Label Image

Duloxetine Fig6

FDA Label Image

Duloxetine Fig8

Duloxetine Fig8
This text provides information on a medication called Duloxetine that is taken once daily at a dose of either 60 or 120 mg for the treatment of pain. The document also includes a chart showing the percentage of pain improvement from baseline. There is an image with numbers that is unclear what purpose it serves.*
FDA Label Image

Duloxetine Fig9

Duloxetine Fig9
The text appears to be a chart or a graph with a comparison of the effects of Placebo and Duloxetine 60 mg on pain improvement in percentage. Therefore, it is not possible to generate a useful description.*
FDA Label Image

Duloxetine-structure (Duloxetine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.